The invention provides a product combination or composition and also multispecific antibodies comprising two or more antigen binding sites (as antibodies or antigen binding fragments thereof) wherein two the antigen binding bind to distinct non overlapping epitopes of the human c-Met protein. The product combination or composition or multispecific antibody inhibits HGF-independent activation of the human c-Met receptor protein.